STOCK TITAN

Iqvia Hldgs Inc - IQV STOCK NEWS

Welcome to our dedicated page for Iqvia Hldgs news (Ticker: IQV), a resource for investors and traders seeking the latest updates and insights on Iqvia Hldgs stock.

IQVIA Holdings Inc. (IQV) delivers integrated healthcare insights through its unique combination of clinical research expertise and advanced data analytics. This news hub provides investors and industry professionals with timely updates on corporate developments shaping the life sciences sector.

Access official press releases and curated news coverage spanning clinical trial milestones, healthcare data partnerships, regulatory updates, and technology innovations. Our collection serves as a strategic resource for understanding IQVIA's role in optimizing drug development cycles and commercial decision-making.

Key content categories include earnings announcements, merger/acquisition activity, leadership changes, and analytical breakthroughs in real-world evidence applications. Bookmark this page for efficient tracking of IQVIA's progress in transforming clinical research through data-driven solutions.

Rhea-AI Summary
IQVIA has been awarded the 'Best AI-based Solution for Healthcare' in the AI Breakthrough Awards. The company's AI software, including natural language processing technology, provides unique insights into patient care and disease states. IQVIA's software is used to analyze complex patient data and unlock critical insights for population health. One use case showed a 56% increase in identifying and screening at-risk patients based on social determinants of health. IQVIA's AI solution is praised for its reliability, repeatability, and transparency.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.39%
Tags
AI
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.11%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.28%
Tags
partnership
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.86%
Tags
none
-
Rhea-AI Summary
IQVIA Holdings Inc. announces the pricing of $1.25 billion in senior notes offering. The offering consists of $750 million in senior secured notes due 2028 and $500 million in senior notes due 2030. The proceeds will be used to repay existing borrowings and cover expenses related to the offering.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.04%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.24%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.95%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.32%
Tags
none
-
Rhea-AI Summary

IQVIA Holdings Inc. reported a first-quarter 2023 revenue of $3,652 million, a 2.4% increase year-over-year. GAAP net income stood at $289 million, with diluted earnings per share of $1.53. Adjusted EBITDA reached $851 million, up 10.4% year-over-year. R&D Solutions saw a significant growth in booked contracts, totaling $2.6 billion, leading to a book-to-bill ratio of 1.28x. The contracted backlog for R&D Solutions reached $27.9 billion, a 10.1% year-over-year increase. The company reaffirmed its full-year 2023 guidance, anticipating revenue between $15,150 million and $15,400 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.33%
Tags
none
Rhea-AI Summary

IQVIA (NYSE:IQV) has been recognized as a Leader in Customer Experience Platforms (CXP) by Everest Group for its Orchestrated Customer Engagement (OCE) platform. This Salesforce-based solution provides a comprehensive suite of capabilities aimed at enhancing customer engagement for life sciences companies. The OCE platform is praised for its efficiency, actionable analytics, and industry-specific best practices, making it a preferred choice among biopharma clients. Everest Group highlights IQVIA's strong customer engagement capabilities as a key differentiator in a competitive landscape. The recognition underscores IQVIA's commitment to delivering innovative analytics and technology solutions that support clinical development and commercialization in the life sciences sector.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.62%
Tags
none
Iqvia Hldgs Inc

NYSE:IQV

IQV Rankings

IQV Stock Data

25.37B
174.77M
0.88%
95.89%
1.99%
Diagnostics & Research
Services-commercial Physical & Biological Research
Link
United States
DURHAM